← back to search

William B. Messer

Portland State University · US
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, and COVID-19 Clinical Research Studies.
h-index
31
citations
4,765
works
147
NIH funding
primary concept
email

Recent publications

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Communications Medicine 2026cited by 1position: middledoi
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Nature Microbiology 2026cited by 1position: middledoi
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
Nature Communications 2025cited by 5position: middledoi
A multiomics recovery factor predicts long COVID in the IMPACC study
Journal of Clinical Investigation 2025cited by 3position: middledoi
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
medRxiv 2025cited by 2position: middledoi
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
JCI Insight 2025cited by 1position: middledoi
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
Journal of Allergy and Clinical Immunology Global 2025cited by 1position: middledoi
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
JCI Insight 2025cited by 1position: middledoi
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Frontiers in Medicine 2025cited by 0position: middledoi
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
PubMed 2025cited by 0position: middledoi
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications 2024cited by 57position: middledoi
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
Nature Communications 2024cited by 25position: middledoi
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 15position: middledoi
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
EBioMedicine 2023cited by 1position: middledoi
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
Science Immunology 2022cited by 334position: middledoi
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
EBioMedicine 2022cited by 73position: middledoi
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
medRxiv 2022cited by 10position: middledoi
A global lipid map defines a network essential for Zika virus replication
Nature Communications 2020cited by 99position: middledoi
Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology
Nature Communications 2018cited by 206position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fikadu Tafesse · Oregon Health & Science University2 papers (2020–2022)Joon‐Yong Lee · Iowa State University2 papers (2020–2022)Hans C. Leier · University School2 papers (2020–2022)Zoë L. Lyski · Oregon Health & Science University1 papers (2022–2022)Endale G. Tafesse · University of Saskatchewan1 papers (2020–2020)Jennifer Kyle · Pacific Northwest National Laboratory1 papers (2020–2020) · 1 papers (2020–2020)Savannah K. McBride · Oregon Health & Science University1 papers (2022–2022)Thomas Metz · Pacific Northwest National Laboratory1 papers (2020–2020)Thorsten Hornemann · University Hospital of Zurich1 papers (2020–2020)Edward A. Dennis · UC San Diego Health System1 papers (2020–2020)Aaron R. Navratil · Theravance Biopharma (United States)1 papers (2020–2020)Bradie Winders · Portland State University1 papers (2022–2022)Devin Schoen · Berkeley College1 papers (2022–2022)Timothy A. Bates · Oregon Health & Science University1 papers (2022–2022)Lisa Bramer · University of Chicago1 papers (2020–2020)Marcel E. Curlin · Oregon Health & Science University1 papers (2022–2022) · 1 papers (2020–2020)Gaelen Guzman · Oregon Health & Science University1 papers (2022–2022)David X. Lee · Oregon Health & Science University1 papers (2022–2022)